Evidence map›Paper›PMID 31451502›Full record

ArticleAntimicrobial agents and chemotherapy2019

Decyl Gallate as a Possible Inhibitor of N-Glycosylation Process in

Ana Carolina Alves de Paula E Silva, Haroldo Cesar de Oliveira, Liliana Scorzoni, Caroline Maria Marcos, Claudia Tavares Dos Santos, Ana Marisa Fusco-Almeida, Ana Carolina Guerta Salina, Alexandra Ivo Medeiros, Fausto Almeida, Sheena Claire Li and 2 more

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Polypeptides TargetingJournal of fungi (Basel, Switzerland) · 2023
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Ana Carolina Alves de Paula E SilvaDepartment of Clinical Analysis, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista, Araraquara, São Paulo, Brazil ana_alpasi@hotmail.com gianninimj@gmail.com.ORCID 0000-0001-5296-1514
Haroldo Cesar de OliveiraDepartment of Clinical Analysis, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista, Araraquara, São Paulo, Brazil.
Liliana ScorzoniDepartment of Clinical Analysis, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista, Araraquara, São Paulo, Brazil.
Caroline Maria MarcosDepartment of Clinical Analysis, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista, Araraquara, São Paulo, Brazil.
Claudia Tavares Dos SantosDepartment of Clinical Analysis, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista, Araraquara, São Paulo, Brazil.
Ana Marisa Fusco-AlmeidaDepartment of Clinical Analysis, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista, Araraquara, São Paulo, Brazil.
Ana Carolina Guerta SalinaDepartment of Biological Sciences, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista, Araraquara, São Paulo, Brazil.
Alexandra Ivo MedeirosDepartment of Biological Sciences, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista, Araraquara, São Paulo, Brazil.
Fausto AlmeidaDepartment of Cellular/Molecular Biology and Pathogenic Bioagents, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil.
Sheena Claire LiDepartment of Molecular Genetics, Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada.
Charles BooneDepartment of Molecular Genetics, Terrence Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada.
Maria J S Mendes-GianniniDepartment of Clinical Analysis, Faculdade de Ciências Farmacêuticas, Universidade Estadual Paulista, Araraquara, São Paulo, Brazil ana_alpasi@hotmail.com gianninimj@gmail.com.
Universidade Estadual Paulista (Unesp) · BRUniversidade de Ribeirão Preto · BRUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The available antifungal therapeutic arsenal is limited. The search for alternative drugs with fewer side effects and new targets remains a major challenge. Decyl gallate (G14) is a derivative of gallic acid with a range of biological activities and broad-spectrum antifungal activity. Previously, our group demonstrated the promising anti-

Indexed as

A549 CellsAntifungal AgentsCell Line, TumorCell WallChitinFungal ProteinsGallic AcidGlycosylationGreen Fluorescent ProteinsHumansLungMitochondriaParacoccidioidesParacoccidioidomycosisSaccharomyces cerevisiaeUnfolded Protein ResponseAntifungal AgentsChitinFungal ProteinsGallic AcidGreen Fluorescent Proteinschemical-genetic interactiondecyl gallatemechanisms of actionN-glycosylationParacoccidioides lutzii

Identifiers

PMID31451502
PMCPMC6811398
OpenAlexW2969650851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.